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Adult T-cell Leukemia/Lymphoma (ATL) is rarely seen in the U.S. and Europe, usually limited to African Americans from the
southeastern U.S. and immigrants from HTLV-1 endemic areas. Reaching an accurate and timely diagnosis of ATL in such
nonendemic areas can be challenging, owing to limited exposure, diverse manifestations, and varying cell morphology. We present
a case of chronic adult T-cell leukemia (ATL) with Chronic Lymphocytic Leukemia- (CLL-) like morphology that remained
untreated for ten years and then developed treatment refractory acute ATL crisis.
1.Introduction
Adult T-cell leukemia/lymphoma (ATL) is a highly aggres-
sive neoplasm of postthymic pleomorphic activated T
lymphocytes, with a mean survival of 6–11 months [1].
Although endemic in southern Japan, the Caribbean, and
Central/South America, HTLV-1 infection and ATL have
only rarely been reported in the U.S. and Europe, usually
limited to African Americans from the southeastern U.S. and
immigrants from HTLV-1 endemic areas. The diversity of
cell morphology in ATL is well known but its implication on
overall clinical outcome has not been fully explored [2]. We
present a case of chronic adult T-cell leukemia-lymphoma
(ATL) with Chronic Lymphocytic Leukemia- (CLL-) like
morphology that remained untreated for ten years and then
developed treatment refractory Acute ATL crisis.
2. Case Presentation
A 57-year-old Caucasian man diagnosed with T-cell leu-
kemia 10 years previously, presented in the outpatient clinic
with worsening abdominal distension. A comprehensive
review of systems revealed decreased appetite with a 30lb
weight loss over 4-5 weeks, nausea, vomiting, dry cough,
and night sweats. He denied any history of intravenous drug
abuse, blood transfusion, or travel outside the United States.
On initial physical examination the patient was noted to
have diﬀuse lymphadenopathy in the axillary and inguinal
regions. Breath sounds were decreased diﬀusely and mild
bibasilar crackles were noted. Cardiovascular exam was
normal. Abdominal examination revealed moderate ascites
with hepatosplenomegaly. He had a scaly macular skin lesion
over his sacrum, measuring approximately 9cm by 4cm.
The patient had been diagnosed at an outside facility
with T-Pro Lymphocytic Leukemia (T-PLL) in 1998 based
on leukocytosis with lymphocytosis, 21300,cu.mm and
presence of relatively uniform lymphocytes with mild abnor-
mality in the nuclear shape, prominent central nucleoli, and
scant cytoplasm, expressing CD2 (97% cells), CD3 (93%),
CD4 (92%), and CD5 (96%) on ﬂow cytometry. CLL-
like small mature lymphocyte morphology was observed in
more than 60% of the cell examined. Sadly, ATL was not
considered in the diﬀerential at the time of initial diagnosis.
The patient stayed asymptomatic from his disease for over
10 years with no evidence of anemia, thrombocytopenia,
splenomegaly, or palpable lymphadenopathy.
Initial laboratory results in our institution revealed leu-
kocytosis 281,900cu.mm with deranged LFTs, elevated LDH
330mg/dl, albumin 1gm/dl, BUN 31mg/dl and calcium,
13.9mg/dl. CT-abdomen revealed hepatosplenomegaly with
generalized lymphadenopathy. Serology for Hepatitis A,
B, and C was negative, as was the serology for human2 Case Reports in Medicine
Figure 1: Peripheral blood smear showing leukemic cells with
varying cell morphologies (including CLL-like small lymphocytes).
immunodeﬁciency viruses 1 and 2 (HIV1 and 2). Computed
Tomography (CT) scans of chest, abdomen, and pelvis at
our institution revealed generalized lymphadenopathy in the
chest, abdomen and pelvis with enlarged liver and moderate
splenomegaly. Skeletal survey revealed no lytic bone lesions.
Peripheral blood smear showed medium to large lym-
phoid cells showing convoluted nuclei, coarsely clumped
chromatin,andbasophilic scantcytoplasmwithﬂoretforms,
blasT-cells, and CLL-like cells (Figures 1 and 2). Flower cells
withpolylobulatednucleiwerealsofoundintheascitesﬂuid.
Immunophenotyping revealed an abnormal T-cell popula-
tion expressing CD2 (96% cells), CD4 (94%), CD5 (95%),
and CD25 (81%) with absent TdT. CD7, a T-cell tumor
marker which aids in diﬀerentiating ATLL from other T-cell
malignancies, was also negative. EIA detected virus speciﬁc
serum antibodies to HTLV-1 which were later conﬁrmed
by Western blotting, thus conﬁrming the diagnosis of ATL.
Trans-Thoracic Echocardiography revealed an ejection frac-
tion of 35% with no regional wall motion abnormalities. The
patient was started on chemotherapy with CEOP regimen
(cyclophosphamide, etoposide, vincristine,and prednisone)
but continued to deteriorate clinically, eventually succumb-
ing to his disease within 3 months of treatment.
3. Discussion
The diagnosis of ATL in nonendemic regions is challenging
and may be particularly diﬃcult to establish. Clinical suspi-
cion is usually based on a constellation of clinical features
and laboratory investigations including lymphocyte mor-
phology, immunophenotype, histology of the aﬀectedtissues
and serology, or DNA analysis for HTLV-I. Organomegaly,
skin involvement, circulating atypical lymphocytes (“ﬂower”
cells) with a CD4+ CD25+ phenotype, and hypercalcemia
are the most common disease features at the time of
presentation [3]. The diﬀerential diagnosis often includes
other mature T-cellneoplasms such as T-cell prolymphocytic
leukaemia (T-PLL), S´ ezary syndrome (SS), and peripheral T-
cell lymphomas.
The diverse clinical features of ATL have led to its sub-
classiﬁcationintoacute,lymphoma,chronic,andsmoldering
Figure 2: A Flower cell in the peripheral smear characteristic of
ATL.
types [4]. The clinical courses of the chronic and smoldering
types are indolent, conventional chemotherapy does not
improve prognosis except in patients with an unfavorable
chronic type who present with lactate dehydrogenase or
blood urea nitrogen levels above the normal upper limits,
and an albumin level below the normal lower limit [5].
Patients with acute transformation generally have a poor
prognosis because of multidrug resistance of malignanT-
cells and a large tumor burden with hypercalcemia and
multiorgan failure. Approximately three-fourths of chronic-
ATLpatientsdiewithin4yearsofdiagnosis[5].Interestingly,
our patient had an asymptomatic course for at least 10
years before presenting with acute crisis, which we believe is
because of the unusual tumor morphology.
ATL cells in peripheral blood (PB) are usually charac-
terized by having highly indented or lobulated nuclei with
homogeneous and condensed chromatin, small or absent
nucleoli, and agranular and basophilic cytoplasm. However,
the diversity of morphology in ATL is well-established and
several cases with peculiar morphological features have been
reported. In addition to polylobed cells, some blastic cells
with basophilic cytoplasm are almost always seen in blood
ﬁlms of ATL [6] .Af e wc a s e sw i t hp r e s e n c eo fb i z a r r eg i a n T -
cells or large granular lymphocytes [7, 8] have also been
reported, and shown to have aggressive clinical features and
ap o o rp r o g n o s i s .
ATL with CLL-like morphology is rare but has been
suggested to have a longer transformation-free survival in a
Japanese study by Tsukasaki et al. [2]. It was reported that
cases with >50% CLL-like cells (n = 7; all chronic type) were
younger (53.1 ± 12.2 versus 66.9 ± 10.6 years; P = .038) and
showed longer acute-crisis free survival (mean: 16.7 versus
3. 0 years; P = .012) than chronic cases with <50% CLL-
like cells. The authors went on to suggest that CLL-like ATL
maybe an earlier phase of ATL leukemogenesis would appear
to be a good prognostic factor for chronic type.
To conclude, the behavior of ATL in our case further
substantiates the thought thaT-cell morphology is closely
associated with genotype, phenotype, and clinical picture
of ATL. The case also highlights the potential diﬃculties
in reaching an accurate and timely diagnosis of ATL inCase Reports in Medicine 3
nonendemicareas,owingtodiversemanifestationsandvary-
ing cell morphology. A close coordination between the pat-
hologist and the clinician is vital in patients with rare disease
pathology and unusual cell morphologies, as a misdiagnosis
can have important clinical implications.
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